308 related articles for article (PubMed ID: 32671737)
1. Autophagy and Parkinson's Disease.
Lu J; Wu M; Yue Z
Adv Exp Med Biol; 2020; 1207():21-51. PubMed ID: 32671737
[TBL] [Abstract][Full Text] [Related]
2. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease.
Zhang K; Zhu S; Li J; Jiang T; Feng L; Pei J; Wang G; Ouyang L; Liu B
Acta Pharm Sin B; 2021 Oct; 11(10):3015-3034. PubMed ID: 34729301
[TBL] [Abstract][Full Text] [Related]
3. Role of the endolysosomal system in Parkinson's disease.
Vidyadhara DJ; Lee JE; Chandra SS
J Neurochem; 2019 Sep; 150(5):487-506. PubMed ID: 31287913
[TBL] [Abstract][Full Text] [Related]
4. Genetic causes of Parkinson's disease and their links to autophagy regulation.
Pan PY; Yue Z
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S154-7. PubMed ID: 24262170
[TBL] [Abstract][Full Text] [Related]
5. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
6. Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.
Senkevich K; Gan-Or Z
Parkinsonism Relat Disord; 2020 Apr; 73():60-71. PubMed ID: 31761667
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
[TBL] [Abstract][Full Text] [Related]
8. Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study.
Aimaiti M; Wumaier A; Aisa Y; Zhang Y; Xirepu X; Aibaidula Y; Lei X; Chen Q; Feng X; Mi N
Eur J Pharmacol; 2021 Jul; 903():174136. PubMed ID: 33940032
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.
Lang M; Pramstaller PP; Pichler I
Mol Neurodegener; 2022 Jul; 17(1):50. PubMed ID: 35842725
[TBL] [Abstract][Full Text] [Related]
10.
Li W; Fu Y; Halliday GM; Sue CM
Front Cell Dev Biol; 2021; 9():612476. PubMed ID: 34295884
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and LRRK2 in the Aging Brain.
Albanese F; Novello S; Morari M
Front Neurosci; 2019; 13():1352. PubMed ID: 31920513
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.
Moors TE; Hoozemans JJ; Ingrassia A; Beccari T; Parnetti L; Chartier-Harlin MC; van de Berg WD
Mol Neurodegener; 2017 Jan; 12(1):11. PubMed ID: 28122627
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
Xilouri M; Brekk OR; Stefanis L
Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
[TBL] [Abstract][Full Text] [Related]
15. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
[TBL] [Abstract][Full Text] [Related]
16. Defective autophagy in Parkinson's disease: lessons from genetics.
Zhang H; Duan C; Yang H
Mol Neurobiol; 2015 Feb; 51(1):89-104. PubMed ID: 24990317
[TBL] [Abstract][Full Text] [Related]
17. Glucocerebrosidase deficits in sporadic Parkinson disease.
Murphy KE; Halliday GM
Autophagy; 2014 Jul; 10(7):1350-1. PubMed ID: 24915553
[TBL] [Abstract][Full Text] [Related]
18. Iron Dysregulation in Parkinson's Disease: Focused on the Autophagy-Lysosome Pathway.
Chen LL; Huang YJ; Cui JT; Song N; Xie J
ACS Chem Neurosci; 2019 Feb; 10(2):863-871. PubMed ID: 30590010
[TBL] [Abstract][Full Text] [Related]
19. Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose.
Li J; Li S; Zhang L; Ouyang L; Liu B
Oncotarget; 2015 Dec; 6(38):40480-95. PubMed ID: 26415234
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of the Lysosome in Parkinson's Disease.
Navarro-Romero A; Montpeyó M; Martinez-Vicente M
Cells; 2020 Nov; 9(11):. PubMed ID: 33147750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
